You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 7, August 19, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Comparison of HIV-antibody prevalence in patients consenting to and declining HIV-antibody testing in an STD clinic

H. F. Hull, C. J. Bettinger, M. M. Gallaher, N. M. Keller, J. Wilson and G. J. Mertz
New Mexico Health and Environment Department, Santa Fe 87504-0968.

All patients attending a sexually transmitted disease (STD) clinic were offered voluntary, anonymous human immunodeficiency virus (HIV)-antibody testing and counseling as part of routine clinical evaluation. During a three-month evaluation period, 82% of patients accepted HIV testing. Testing was accepted equally by men and women and by heterosexual and homosexual men. Black men were more likely to refuse testing than men from other ethnic groups. Eight (0.7%) of 1146 STD clinic patients tested were infected with HIV. A blinded study of 237 patients who refused testing identified nine (3.8%) additional HIV-infected patients. Men who refused testing were 5.3 times more likely to be infected than men who accepted testing. Male homosexuals and black and Hispanic men who refused testing were 7.3 and 8.8 times, respectively, more likely to be infected with HIV than were their counterparts who accepted testing. Human immunodeficiency virus testing and counseling should be routinely offered to STD clinic patients. Male STD clinic patients, especially homosexual or minority men, who refuse voluntary HIV testing should be counseled regarding reducing their risk for HIV transmission.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

HIV testing attitudes, AIDS stigma, and voluntary HIV counselling and testing in a black township in Cape Town, South Africa
Kalichman and Simbayi
Sex. Transm. Infect. 2003;79:442-447.
ABSTRACT | FULL TEXT  

Unrecognized HIV Infection Among Patients Attending Sexually Transmitted Disease Clinics
Weinstock et al.
Am. J. Public Health 2002;92:280-283.
ABSTRACT | FULL TEXT  

The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom
Nicoll et al.
Int J Epidemiol 2000;29:1-10.
ABSTRACT | FULL TEXT  

Critical Delays in HIV Testing and Care: The Potential Role of Stigma
CHESNEY and SMITH
American Behavioral Scientist 1999;42:1162-1174.
ABSTRACT  

The Cost-Effectiveness of HIV Testing: Accounting for Differential Participation Rates
Paltiel and Kaplan
Med Decis Making 1997;17:490-495.
ABSTRACT  

The American, British and Dutch Responses to Unlinked Anonymous HIV Seroprevalence Studies: An International Comparison
Bayer et al.
J Law Med Ethics 1991;19:222-230.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.